Greece Neurology Devices Investment Opportunities, Analysis and Projections to 2017

• Publication date: May 2012
• Report size: 103 pages

The report provides value (USD million), volume (units) and average price (USD) data for each sector and sub-segment within five industry categories – Neurostimulation Devices, Neurological Diagnostic Equipment, Interventional Neurology, CSF Management and Neurosurgical Products. The report also provides industry player shares and distribution shares data for each of the aforementioned industry categories. The report is supplemented with globa...

The report provides value (USD million), volume (units) and average price (USD) data for each sector and sub-segment within five industry categories – Neurostimulation Devices, Neurological Diagnostic Equipment, Interventional Neurology, CSF Management and Neurosurgical Products. The report also provides industry player shares and distribution shares data for each of the aforementioned industry categories. The report is supplemented with global corporate-level profiles of the key industry participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Industry s Direct’s team of market experts.

Scope of the Research

- Industry size and industry player share data for Neurology Devices industry categories – Neurostimulation Devices, Neurological Diagnostic Equipment, Interventional Neurology, CSF Management and Neurosurgical Products.
- Annualized industry revenues (USD million), volume (units) and average price (USD) data for each of the sectors and sub-segments within five industry categories. Data from 2003 to 2010, projection forward for 7 years to 2017.
- 2010 industry player shares and distribution shares data for each of the five industry categories.
- Global corporate-level profiles of top industry players operating within the Greece Neurology Devices industry .
- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., B. Braun Melsungen AG, DePuy, Inc., Terumo Corporation and others.

Reasons to buy

- Develop business strategies by identifying the key industry categories and sectors poised for strong growth.
- Develop industry -entry and industry expansion strategies.
- Design competition strategies by identifying who-stands-where in the Greece Neurology Devices competitive landscape.
- Develop capital investment strategies by identifying the key industry sectors expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

General Medicine And Specialty Medicine Industry in Greece

Table of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 10
2.1 What is This Report About? 10
3 Neurology Devices In Greece 11
3.1 Neurology Devices, Greece, Overall Revenue ($m), from 2003 to 2017 11
3.2 Neurology Devices, Greece, Category Volume (Units), from 2003 to 2017 17
3.3 Neurology Devices, Greece, Firms Share (2009-2010) 22
4 CSF Management In Greece 24
4.1 CSF Management Overall Revenue (2003-2017) 24
4.2 CSF Management Overall Volume (2003-2017) 27
4.3 CSF Management Average Price (2003-2017) 31
4.4 CSF Management Distribution Share (2009-2010) 32
4.5 CSF Management, Greece, Firms Share (2009-2010) 33
5 Interventional Neurology In Greece 35
5.1 Interventional Neurology Overall Revenue (2003-2017) 35
5.1.1 Embolic Systems Revenue (2003-2017) 39
5.1.2 Navigational Systems Revenue (2003-2017) 43
5.2 Interventional Neurology Overall Volume (2003-2017) 45
5.2.1 Embolic Systems Volume (2003-2017) 49
5.2.2 Navigational Systems Volume (2003-2017) 52
5.3 Interventional Neurology Average Price (2003-2017) 55
5.4 Interventional Neurology Distribution Share (2009-2010) 56
5.5 Interventional Neurology, Greece, Firms Share (2009-2010) 57
6 Neurological Diagnostic Equipment In Greece 59
6.1 Neurological Diagnostic Equipment Overall Revenue (2003-2017) 59
6.2 Neurological Diagnostic Equipment Overall Volume (2003-2017) 63
6.3 Neurological Diagnostic Equipment Average Price (2003-2017) 67
6.4 Neurological Diagnostic Equipment Distribution Share (2009-2010) 68
6.5 Neurological Diagnostic Equipment, Greece, Firms Share (2009-2010) 69
7 Neurostimulation Devices In Greece 71
7.1 Neurostimulation Devices Overall Revenue (2003-2017) 71
7.2 Neurostimulation Devices Overall Volume (2003-2017) 75
7.3 Neurostimulation Devices Average Price (2003-2017) 79
7.4 Neurostimulation Devices Distribution Share (2009-2010) 80
7.5 Neurostimulation Devices, Greece, Firms Share (2009-2010) 81
8 Neurosurgical Products In Greece 82
8.1 Neurosurgical Products Overall Revenue (2003-2017) 82
8.2 Neurosurgical Products Overall Volume (2003-2017) 84
8.3 Neurosurgical Products Average Price (2003-2017) 87
8.4 Neurosurgical Products Distribution Share (2009-2010) 88
8.5 Neurosurgical Products, Greece, Firms Share (2009-2010) 89
9 Radiosurgery In Greece 91
9.1 Radiosurgery Overall Revenue (2003-2007) 91
9.2 Radiosurgery Overall Volume (2003-2007) 92
9.3 Radiosurgery Average Price (2003-2007) 93
10 Overview of Key Firms in Greece Neurology Devices March ket 94
10.1 Medtronic, Inc. 94
10.1.1 Corporate Presentation 94
10.2 Boston Scientific Corporation 94
10.2.1 Corporate Presentation 94
10.3 St. Jude Medical, Inc. 95
10.3.1 Corporate Presentation 95
10.4 B. Braun Melsungen AG 95
10.4.1 Corporate Presentation 95
10.5 DePuy, Inc. 95
10.5.1 Corporate Presentation 95
10.6 Covidien plc 96
10.6.1 Corporate Presentation 96
10.7 Terumo Corporation 96
10.7.1 Corporate Presentation 96
10.8 Natus Medical Incorporated 96
10.8.1 Corporate Presentation 96
10.9 Integra LifeSciences Holdings Corporation 97
10.9.1 Corporate Presentation 97
10.10 Cadwell Laboratories, Inc. 97
10.10.1 Corporate Presentation 97
10.11 Micrus Endovascular Corporation 97
10.11.1 Corporate Presentation 97
10.12 CareFusion Corporation 98
10.12.1 Corporate Presentation 98
10.13 ev3 Inc. 98
10.13.1 Corporate Presentation 98
10.14 Cyberonics, Inc. 99
10.14.1 Corporate Presentation 99
10.15 Sophysa S.A. 99
10.15.1 Corporate Presentation 99
10.16 Micromed S.p.A 99
10.16.1 Corporate Presentation 99
10.17 KARL STORZ GmbH & Co. KG 100
10.17.1 Corporate Presentation 100
10.18 Nihon Kohden Corporation 100
10.18.1 Corporate Presentation 100
11 Appendix 101
11.1 Global March kets Direct Research Methodology 101
11.2 Definitions of March kets Covered in the Report 102
11.2.1 Neurology Devices 102
11.3 Secondary Research 104
11.4 Primary Research 105
11.5 Models 105
11.6 Projections 106
11.7 Expert Panel Validation 106
11.8 Currency Conversion 106
11.9 Contact Us 107
11.10 Disclaimer 107

List of Tables

1.1 List of Tables
Table 1: Neurology Devices, Greece, Overall Revenue ($m), from 2003 to 2017 12
Table 2: Neurology Devices, Greece, Overall Revenue ($m), Historic, from 2003 to 2010 14
Table 3: Neurology Devices, Greece, Overall Revenue ($m), Projection , from 2010 to 2017 16
Table 4: Neurology Devices, Greece, Category Volume (Units), from 2003 to 2017 17
Table 5: Neurology Devices, Greece, Category Volume (Units), Historic, from 2003 to 2010 19
Table 6: Neurology Devices, Greece, Category Volume (Units), Projection , from 2010 to 2017 21
Table 7: Neurology Devices, Greece, Firms Share by Revenue ($m), from 2009 to 2010 23
Table 8: CSF Management, Greece, Revenue ($m) by Segment, Historic, from 2003 to 2010 25
Table 9: CSF Management, Greece, Revenue ($m) by Segment, Projection , from 2010 to 2017 26
Table 10: CSF Management, Greece, Volume (Units) by Segment, Historic, from 2003 to 2010 28
Table 11: CSF Management, Greece, Volume (Units) by Segment, Projection , from 2010 to 2017 30
Table 12: CSF Management, Greece, Average Price ($), Historic, from 2003 to 2010 31
Table 13: CSF Management, Greece, Average Price ($), Projection , from 2010 to 2017 31
Table 14: CSF Management, Greece, Distribution Share by Revenue ($m), from 2009 to 2010 32
Table 15: CSF Management, Greece, Firms Share by Revenue ($m), from 2009 to 2010 34
Table 16: Interventional Neurology, Greece, Revenue ($m) by Segment, Historic, from 2003 to 2010 36
Table 17: Interventional Neurology, Greece, Revenue ($m) by Segment, Projection , from 2010 to 2017 38
Table 18: Embolic Systems, Greece, Revenue ($m) by Sub-Segment, Historic, from 2003 to 2010 40
Table 19: Embolic Systems, Greece, Revenue ($m) by Sub-Segment, Projection , from 2010 to 2017 42
Table 20: Navigational Systems, Greece, Revenue ($m) by Sub-Segment, Historic, from 2003 to 2010 43
Table 21: Navigational Systems, Greece, Revenue ($m) by Sub-Segment, Projection , from 2010 to 2017 44
Table 22: Interventional Neurology, Greece, Volume (Units) by Segment, Historic, from 2003 to 2010 46
Table 23: Interventional Neurology, Greece, Volume (Units) by Segment, Projection , from 2010 to 2017 48
Table 24: Embolic Systems, Greece, Volume (Units) by Sub-Segment, Historic, from 2003 to 2010 50
Table 25: Embolic Systems, Greece, Volume (Units) by Sub-Segment, Projection , from 2010 to 2017 51
Table 26: Navigational Systems, Greece, Volume (Units) by Sub-Segment, Historic, from 2003 to 2010 53
Table 27: Navigational Systems, Greece, Volume (Units) by Sub-Segment, Projection , from 2010 to 2017 54
Table 28: Interventional Neurology, Greece, Average Price ($), Historic, from 2003 to 2010 55
Table 29: Interventional Neurology, Greece, Average Price ($), Projection , from 2010 to 2017 55
Table 30: Interventional Neurology, Greece, Distribution Share by Revenue ($m), from 2009 to 2010 56
Table 31: Interventional Neurology, Greece, Firms Share by Revenue ($m), from 2009 to 2010 58
Table 32: Neurological Diagnostic Equipment, Greece, Revenue ($m) by Segment, Historic, from 2003 to 2010 60
Table 33: Neurological Diagnostic Equipment, Greece, Revenue ($m) by Segment, Projection , from 2010 to 2017 62
Table 34: Neurological Diagnostic Equipment, Greece, Volume (Units) by Segment, Historic, from 2003 to 2010 64
Table 35: Neurological Diagnostic Equipment, Greece, Volume (Units) by Segment, Projection , from 2010 to 2017 66
Table 36: Neurological Diagnostic Equipment, Greece, Average Price ($), Historic, from 2003 to 2010 67
Table 37: Neurological Diagnostic Equipment, Greece, Average Price ($), Projection , from 2010 to 2017 67
Table 38: Neurological Diagnostic Equipment, Greece, Distribution Share by Revenue ($m), from 2009 to 2010 68
Table 39: Neurological Diagnostic Equipment, Greece, Firms Share by Revenue ($m), from 2009 to 2010 70
Table 40: Neurostimulation Devices, Greece, Revenue ($m) by Segment, Historic, from 2003 to 2010 72
Table 41: Neurostimulation Devices, Greece, Revenue ($m) by Segment, Projection , from 2010 to 2017 74
Table 42: Neurostimulation Devices, Greece, Volume (Units) by Segment, Historic, from 2003 to 2010 76
Table 43: Neurostimulation Devices, Greece, Volume (Units) by Segment, Projection , from 2010 to 2017 78
Table 44: Neurostimulation Devices, Greece, Average Price ($), Historic, from 2003 to 2010 79
Table 45: Neurostimulation Devices, Greece, Average Price ($), Projection , from 2010 to 2017 79
Table 46: Neurostimulation Devices, Greece, Distribution Share by Revenue ($m), from 2009 to 2010 80
Table 47: Neurostimulation Devices, Greece, Firms Share by Revenue ($m), from 2009 to 2010 81
Table 48: Neurosurgical Products, Greece, Revenue ($m) by Segment, Historic, from 2003 to 2010 82
Table 49: Neurosurgical Products, Greece, Revenue ($m) by Segment, Projection , from 2010 to 2017 83
Table 50: Neurosurgical Products, Greece, Volume (Units) by Segment, Historic, from 2003 to 2010 85
Table 51: Neurosurgical Products, Greece, Volume (Units) by Segment, Projection , from 2010 to 2017 86
Table 52: Neurosurgical Products, Greece, Average Price ($), Historic, from 2003 to 2010 87
Table 53: Neurosurgical Products, Greece, Average Price ($), Projection , from 2010 to 2017 87
Table 54: Neurosurgical Products, Greece, Distribution Share by Revenue ($m), from 2009 to 2010 88
Table 55: Neurosurgical Products, Greece, Firms Share by Revenue ($m), from 2009 to 2010 90
Table 56: Radiosurgery, Greece, Revenue ($m) by Segment, Historic, from 2003 to 2007 91
Table 57: Radiosurgery, Greece, Volume (Units) by Segment, Historic, from 2003 to 2007 92
Table 58: Radiosurgery, Greece, Average Price ($), Historic, from 2003 to 2007 93
Table 59: US Dollar to Local Currency, Greece, Average Actual Rate from 2003 to 2010 106

List of Figures

1.2 List of Figures
Figure 1: Neurology Devices, Greece, Overall Revenue ($m), from 2003 to 2017 11
Figure 2: Neurology Devices, Greece, Overall Revenue ($m), Historic, from 2003 to 2010 13
Figure 3: Neurology Devices, Greece, Overall Revenue ($m), Projection , from 2010 to 2017 15
Figure 4: Neurology Devices, Greece, Category Volume (Units), from 2003 to 2017 17
Figure 5: Neurology Devices, Greece, Category Volume (Units), Historic, from 2003 to 2010 18
Figure 6: Neurology Devices, Greece, Category Volume (Units), Projection , from 2010 to 2017 20
Figure 7: Neurology Devices, Greece, Firms Share (%), 2010 22
Figure 8: CSF Management, Greece, Revenue ($m) by Segment, Historic, from 2003 to 2010 24
Figure 9: CSF Management, Greece, Revenue ($m) by Segment, Projection , from 2010 to 2017 26
Figure 10: CSF Management, Greece, Volume (Units) by Segment, Historic, from 2003 to 2010 27
Figure 11: CSF Management, Greece, Volume (Units) by Segment, Projection , from 2010 to 2017 29
Figure 12: CSF Management, Greece, Firms Share (%), 2010 33
Figure 13: Interventional Neurology, Greece, Revenue ($m) by Segment, Historic, from 2003 to 2010 35
Figure 14: Interventional Neurology, Greece, Revenue ($m) by Segment, Projection , from 2010 to 2017 37
Figure 15: Embolic Systems, Greece, Revenue ($m) by Sub-Segment, Historic, from 2003 to 2010 39
Figure 16: Embolic Systems, Greece, Revenue ($m) by Sub-Segment, Projection , from 2010 to 2017 41
Figure 17: Navigational Systems, Greece, Revenue ($m) by Sub-Segment, Historic, from 2003 to 2010 43
Figure 18: Navigational Systems, Greece, Revenue ($m) by Sub-Segment, Projection , from 2010 to 2017 44
Figure 19: Interventional Neurology, Greece, Volume (Units) by Segment, Historic, from 2003 to 2010 45
Figure 20: Interventional Neurology, Greece, Volume (Units) by Segment, Projection , from 2010 to 2017 47
Figure 21: Embolic Systems, Greece, Volume (Units) by Sub-Segment, Historic, from 2003 to 2010 49
Figure 22: Embolic Systems, Greece, Volume (Units) by Sub-Segment, Projection , from 2010 to 2017 51
Figure 23: Navigational Systems, Greece, Volume (Units) by Sub-Segment, Historic, from 2003 to 2010 52
Figure 24: Navigational Systems, Greece, Volume (Units) by Sub-Segment, Projection , from 2010 to 2017 54
Figure 25: Interventional Neurology, Greece, Firms Share (%), 2010 57
Figure 26: Neurological Diagnostic Equipment, Greece, Revenue ($m) by Segment, Historic, from 2003 to 2010 59
Figure 27: Neurological Diagnostic Equipment, Greece, Revenue ($m) by Segment, Projection , from 2010 to 2017 61
Figure 28: Neurological Diagnostic Equipment, Greece, Volume (Units) by Segment, Historic, from 2003 to 2010 63
Figure 29: Neurological Diagnostic Equipment, Greece, Volume (Units) by Segment, Projection , from 2010 to 2017 65
Figure 30: Neurological Diagnostic Equipment, Greece, Firms Share (%), 2010 69
Figure 31: Neurostimulation Devices, Greece, Revenue ($m) by Segment, Historic, from 2003 to 2010 71
Figure 32: Neurostimulation Devices, Greece, Revenue ($m) by Segment, Projection , from 2010 to 2017 73
Figure 33: Neurostimulation Devices, Greece, Volume (Units) by Segment, Historic, from 2003 to 2010 75
Figure 34: Neurostimulation Devices, Greece, Volume (Units) by Segment, Projection , from 2010 to 2017 77
Figure 35: Neurostimulation Devices, Greece, Firms Share (%), 2010 81
Figure 36: Neurosurgical Products, Greece, Revenue ($m) by Segment, Historic, from 2003 to 2010 82
Figure 37: Neurosurgical Products, Greece, Revenue ($m) by Segment, Projection , from 2010 to 2017 83
Figure 38: Neurosurgical Products, Greece, Volume (Units) by Segment, Historic, from 2003 to 2010 84
Figure 39: Neurosurgical Products, Greece, Volume (Units) by Segment, Projection , from 2010 to 2017 86
Figure 40: Neurosurgical Products, Greece, Firms Share (%), 2010 89
Figure 41: Radiosurgery, Greece, Revenue ($m) by Segment, Historic, from 2003 to 2007 91
Figure 42: Radiosurgery, Greece, Volume (Units) by Segment, Historic, from 2003 to 2007 92
Figure 43: Global March kets Direct Methodology 101

Companies Mentioned

Medtronic, Inc.
Boston Scientific Corporation
St. Jude Medical, Inc.
B. Braun Melsungen AG
DePuy, Inc.
Covidien plc
Terumo Corporation
Natus Medical Incorporated
Integra LifeSciences Holdings Corporation
Cadwell Laboratories, Inc.
Micrus Endovascular Corporation
CareFusion Corporation
ev3 Inc.
Cyberonics, Inc.
Sophysa S.A.
Micromed S.p.A
KARL STORZ GmbH & Co. KG
Nihon Kohden Corporation